PFE Stock | News | Quote | Stock Forum | Sunday, November 10,

New Post Public Reply Private Reply Replies (0) Message Board

Nov 10, 2013 at 2:10 PM

$PFE Pfizer, Inc. PFE Company Overview

Stock Message Board http://investorshangout.com/search?q=PFE&...mp;yt1=Go!

Last Updated: Sunday, November 10, 2013 2:10:31 PM

Pfizer, Inc. PFE Current Price and Quotes
Last Price 31.32
Previous Close 30.91 Open 30.88
Daily Range 31.35 - 30.73 52wk Range 31.40 - 23.55
Volume 25,020,360 Dividend 0.96
Average Vol (3m) 25,354,102 Yield 3.0651
Pfizer, Inc. PFE
Company Information

235 East 42nd Street
New York, NY 10017

Website: http://www.pfizer.com
Phone: (212) 573-2323

Pfizer, Inc. PFE
Not Available

Pfizer, Inc. PFE
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Latest Report Sep 29, 2013 10-Q
CIK 0000078003
Fiscal Year End 12/31
OTC Marketplace Not Available
Profile Data

SIC - Industry Classification Not Available
Incorporated In: DE, USA
Year of Inc. Not Available
Employees Not Available
Service Providers

Auditor/Accountant
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available

Pfizer, Inc. PFE
PFE Security Details

Share Structure

Market Value1 $201,257,116,048 a/o Nov 08, 2013
Shares Outstanding 6,620,299,870 a/o Aug 05, 2013
Float Not Available
Authorized Shares Not Available
Par Value 0.05
Shareholders

Shareholders of Record 231,737 a/o Feb 29, 2008
Corporate Actions

Ex. Date Record Date Pay Date
Dividend () Aug 14, 2002 Aug 16, 2002 Sep 05, 2002
Security Notes

Capital Change=shs increased by 2 for 1 split. Ex-date=07-03-95. Rec date=06-01-95. Pay date=06-30-95
Latest Secondary Issue=11-72, 703,447 shs at $43 by Lazard Freres & Co. et al.
Par Changed=10 cents to 5 cents. Basis: 2 for 1 split. Ex-date=07-03-95. Rec date=06-01-95. Pay date=06-30-95
Capital Change=Capital Change=shs increased by 3 for 1 split. . Ex-date=07/01/1999. Rec date=06/02/1999. Pay date=06/30/1999.
Short Selling Data

Short Interest (%)
Significant Failures to Deliver No
Transfer Agent(s)

Pfizer, Inc. PFE Financials
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010 Dec 31, 2009
Total Revenue 58,986,000 65,259,000 65,165,000 49,269,000
Cost of Revenue 11,334,000 14,076,000 14,788,000 8,459,000
Gross Profit 47,652,000 51,183,000 50,377,000 40,810,000
Operating Expenses

Research and Development 7,870,000 9,074,000 9,483,000 7,824,000
Sales, General and Admin. 16,616,000 18,832,000 18,973,000 15,037,000
Non-Recurring Items 1,880,000 2,930,000 3,145,000 4,398,000
Other 5,175,000 5,544,000 5,364,000 2,877,000
Operating Income 16,111,000 14,803,000 13,412,000 10,674,000
Income From Continuing Operations

Add'l Income/Expense Items (4,031,000) (2,499,000) (3,941,000) -
Earnings Before Interest and Tax 12,080,000 12,304,000 9,471,000 10,674,000
Interest Expense - - - -
Earnings Before Tax 12,080,000 12,304,000 9,471,000 10,674,000
Income Tax 2,562,000 3,909,000 1,153,000 2,145,000
Minority Interest 28,000 40,000 31,000 8,000
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations 9,518,000 8,395,000 8,318,000 8,529,000
Non Recurring Events

Discontinued Operations 5,080,000 1,654,000 (30,000) 114,000
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income 14,570,000 10,009,000 8,257,000 8,635,000
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders 14,570,000 10,009,000 8,257,000 8,635,000

Pfizer, Inc. PFE Recent News

Nov 8, 2013 Pfizer Announces Top-Line Results Of Phase 3B/4 Study Of RAPAMUNE(R) (sirolimus) In Renal Transplant Recipients
Nov 7, 2013 GlycoMimetics to Present Five Abstracts at 2013 American Society of Hematology Annual Meeting
Nov 7, 2013 FDA Approvals, Successful Product Launches, Upcoming Earnings Schedules and Quarterly Financial Results - Research Report on Pfizer, Mettler-Toledo, Arena, Wright Medical, and Ophthotech
Nov 6, 2013 2013 mHealth Summit Launches First Pharma and Life Sciences Roundtable
Nov 6, 2013 The Zacks Analyst Blog Highlights: Actelion, Bayer, Pfizer, Gilead Sciences and Honeywell International
Nov 5, 2013 Former U.S. President Jimmy Carter And Pfizer Celebrate 15-Year Effort To Help End Blinding Trachoma As A Public Health Concern
Nov 4, 2013 Pfizer Receives FDA Approval for a Prior Approval Supplement for EMBEDA(R) (morphine sulfate and naltrexone hydrochloride) Extended Release Capsules CII
Nov 4, 2013 Therapeutic Area Partnerships Feature Pharma Leaders Who Unveil How to Pick Drug Targets, Partners, and Deal Models Most Likely to Succeed
Nov 1, 2013 Global Medical Nutrition Market Is Expected To Grow At a Steady Pace, Clocking A CAGR Of 6.7 Percent during the Period 2012-2016
Nov 1, 2013 Dividend, Quarterly Report, Recognition, Study Results, and New Drug Application - Research Report on Pfizer, Lilly, Regeneron, Vertex, and GSK

1
2
3
4
5
6
7
8
next >
last >>

PFE Pfizer, Inc. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=PFE&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/PFE/quote
Stock Chart http://www.otcmarkets.com/stock/PFE/chart
Company Info http://www.otcmarkets.com/stock/PFE/company-info
Recent News http://www.otcmarkets.com/stock/PFE/news
Financials http://www.otcmarkets.com/stock/PFE/financials
Filings and Disclosure http://www.otcmarkets.com/stock/PFE/filings
Short Sales http://www.otcmarkets.com/stock/PFE/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/PFE/insider-transactions
Research Reports http://www.otcmarkets.com/stock/PFE/research
Summary http://finance.yahoo.com/q?s=PFE
Historical Prices http://finance.yahoo.com/q/hp?s=PFE+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=PFE
Basic Chart http://finance.yahoo.com/q/bc?s=PFE+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=PFE+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=PFE+Headlines
Press Releases http://finance.yahoo.com/q/p?s=PFE+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=PFE+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=PFE+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=PFE+Industry
Major Holders http://finance.yahoo.com/q/mh?s=PFE+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=PFE+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=PFE+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=PFE
Balance Sheet http://finance.yahoo.com/q/bs?s=PFE
Cash Flow http://finance.yahoo.com/q/cf?s=PFE+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/PFE
Market Watch http://www.marketwatch.com/investing/stock/PFE
Bloomberg http://www.bloomberg.com/quote/PFE:US
Morningstar http://quotes.morningstar.com/stock/s?t=PFE
Bussinessweek http://investing.businessweek.com/research/st...ticker=PFE
Barchart http://www.barchart.com/quotes/stocks/PFE
OTC Short Report http://otcshortreport.com/index.php?index=PFE
Investopedia http://www.investopedia.com/markets/stocks/PFE/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Amcor's Q3 2026 Results Loom: What's at Stake?

Anticipation Builds for Amcor's Q3 2026 Financials Well, here we are again, staring down the barrel of another quarterly earnings report from Amcor plc (NYSE: AMCR). They've circled November 4th, 2026, in red on their calendars to dish out the numbers after the U.S. market's last bell rings. Investors, analysts, and the peanut gallery will be tuning in, and why not? At a...

Navigating Legal Advice Post-Car Crash: A Crucial Guide

It's a simple blink-and-you-miss-it moment: one second you're cruising down the street, and the next you're in a fender bender. But if you think you can handle everything solo from here on out, think again. A HelloNation article featuring Pittsburgh attorney Frank Walker brings crucial clarity to when and why you might need a lawyer after a car crash. The Misleading Calm...

Genimous Lands a Role as an OpenAI Select Partner

Genimous Teaming Up with OpenAI Genimous just got the nod from OpenAI, bagging a spot as a Select Partner. Now, if you've been paying any attention, you know OpenAI isn’t handing out partnerships like Halloween candy. Genimous got this shiny badge due to its work in digital interaction marketing. We’re talking from gaming to e-commerce, they’ve got the hands in...

InfraMed Expands Team for National Healthcare Growth

InfraMed's Bold Move in Healthcare Real Estate You know, it’s not every day you see a company go all in on healthcare properties like InfraMed’s doing. With the blitz of new personnel, we're talking about a genuine push to carve out a piece of the national market. And if you've been keeping tabs, this isn't just a hunch—they've got serious momentum brewing, and the...

FIBRA Prologis Posts Strong Q3 2026 Results Amid Market Trends

Decoding FIBRA Prologis' Latest Numbers Never a dull moment in industrial real estate, folks—and FIBRA Prologis (BMV:FIBRAPL 14) just dropped its third quarter earnings results for 2026, lighting a fire in its trajectory. On the surface, their numbers seem to belt out a victory anthem, but let's peel back the layers to understand what truly hums under the hood. A...

New American Perspectives Shines at HIFF 2026

Ever notice how the arts can cut through the noise and spotlight voices we often overlook? Well, that's exactly what's happening at the Hawai?i International Film Festival (HIFF) this year. The Vilcek Foundation, alongside HIFF, is bringing the New American Perspectives program back for another round at the festival’s 46th edition, and it's a heck of a lineup....

Selling Your Home? Key Fixes John Spear Recommends

Cracking the Code of Real Estate in Cape Girardeau If you're about to stick that 'For Sale' sign in the lawn, listen up. Cape Girardeau's own real estate legend, John Spear—lovingly dubbed "Mr. Cape Girardeau" for good reason—is spilling the beans on what to spruce up before selling your humble abode. And spoiler alert: it's not about blowing a year's salary on a...

Anrok Integrates AI for Seamless Tax Management Efficiency

Streamlining Tax Management with AI Integration You know, managing tax data can be as thrilling as watching paint dry, but Anrok's latest move might just shake the dullness out of it. San Francisco's own Anrok has rolled out their Anrok MCP, a game-changer that's putting tax management into the fast lane. This isn't just about tossing out the old tax data headaches, it's...

ESENTIA Sets Stage for Q3 2026 Earnings Insights

A Snapshot of What's Coming You know the drill, folks—when the calendar flips close to earnings season, the scramble starts for details that make or break the quarter. ESENTIA Energy Development, the big dog in the Mexican natural gas scene, is poised to drop its third-quarter 2026 numbers right after the market bell sounds on October 28th. They've been flexing their...

SportsMed Expands with Hoboken Clinic Opening

SportsMed's Strategic Hoboken Leap The healthcare landscape in New Jersey and Connecticut's about to get a shake-up, and all eyes should be on SportsMed Physical Therapy. They've just planted their flag in Hoboken with a new clinic, bumping their operational presence up to a whopping 57 clinics. Quite the comeback story from their humble beginnings. Now, that's some...